Gossamer Bio promotes CFO Bryan Giraudo to also serve as COO

Gossamer Bio, Inc.

Bryan Giraudo appointed COO effective Sept 16, 2021, while remaining CFO.
Annual base salary increased to $460,000; target bonus raised to 45% of salary.
Granted option for 150,000 shares under 2019 Equity Incentive Plan; vests over 4 years.
Severance enhanced: 9 months base salary (12 months upon change-in-control) plus bonus and COBRA.
Giraudo joined Gossamer in May 2018 as CFO; previously Senior MD at SVB Leerink.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Bryan Giraudo

Chief Operating Officer/Chief Financial Officer

GOSS · Gossamer Bio, Inc.

Effective: 2021-09-16
Filed: September 21, 2021, 7:59 PM ET

Effective September 16, 2021, Bryan Giraudo was promoted to Chief Operating Officer/Chief Financial Officer of Gossamer Bio, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bryan Giraudo changed role as Chief Operating Officer/Chief Financial Officer at Gossamer Bio, Inc..

Action: promoted
Role: Chief Operating Officer/Chief Financial Officer

Exact text from the filing

Effective September 16, 2021, Bryan Giraudo was promoted to Chief Operating Officer/Chief Financial Officer of Gossamer Bio, Inc.

View on SEC.gov

Gossamer Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001728117-21-000092

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.